Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Seroquel Patent Expiration Leads To Sharp 2Q Revenue Decline For AstraZeneca

Jul 26 2012

Related Content

Brennan’s Departure Not Expected To Disrupt Current Business Development Strategy At AstraZeneca

Apr 30 2012

Brennan’s Abrupt Departure Has Some Viewing AstraZeneca As A Buyout Target

Apr 26 2012

Related Companies

AstraZeneca PLC

Pfizer Inc.

Additional Topics

United Kingdom Europe Business Strategies Intellectual Property BioPharmaceutical

More from United Kingdom

More from Europe

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window